The Siberian pharmaceutical company PFC Obnovleniye, operating under the Renewal brand, invested 4 billion rubles in the production of medicines in glass ampoules in 2025, announced Denis Ryaguzov, Acting Minister of Industry, Trade, and Entrepreneurship Development of the Novosibirsk Region.
“The company continues to implement an investment project worth 4 billion rubles, which includes the construction of three new buildings and the launch of 17 new drugs,” he said (quoted by Kommersant).
In April, Renewal announced plans to build two workshops in 2025–2026 and expand production by launching liquid medicines. It was anticipated that the production capacity, with launch scheduled for December, would amount to 14.5 million packages of drugs in glass ampoules per year.
Renewal’s production facilities are located in the Suzunsky District of the Novosibirsk Region and in Novosibirsk. The company produces medicines in liquid and solid forms, including injection solutions, eye and nasal drops, tablets, capsules, powders, and others.
In October, it was reported that Renewal had changed its general director.
